Skip to main content
Rx Summit Event Banner
* indicates a required field

2022 Call for Presentations

Event Date: April 18-21, 2022
Location: Georgia World Congress Center in Atlanta, GA
Submission Deadline Date: Friday, August 27, 2021

The Rx Summit will notify applicants by the end of November 2021 regarding whether their submission was accepted or declined.

Please read before submitting a presentation proposal.

The Rx Drug Abuse & Heroin Summit is the largest national collaboration of professionals from local, state and federal agencies, business, academia, clinicians, treatment providers, counselors, educators, state and national leaders, law enforcement/ public safety, and advocates impacted by the opioid crisis.

The programs and presentations will be tailored to provide stakeholders timely and relevant information for their particular fields. Submissions will be reviewed by the Rx Summit’s National Advisory Board members, who represent multi-disciplinary interests.

Please be prepared to submit the following:
  • Session/Poster title
  • Abstract (max 250 words)
  • Relevant evidence (max 250 words)
  • Relevance to Rx Summit audience (max 150 words)
  • Three (3) learning objectives
  • Three (3) practical take-aways
  • Identification of topic area (listed below)
  • Presenter details to include profile information and conflict of interest documentation

The Rx Summit will be accepting presentation proposals that accommodate the following formats:
  • Breakout Sessions (75-minutes, including a question and answer segment)
  • Posters (which will be featured in the exhibit hall and have designated poster presentation times when presenters will be required to stand by their posters)

Please note the following limits:
  • Limit of 4 presenters per breakout session, but 2 presenters are preferred. Per breakout session, up to 2 presenters are eligible for complimentary registration, complimentary hotel room, and travel reimbursement (see Rx Summit Presentation Terms and Conditions).
  • Limit of 1 presenter per poster.
  • Limit of 3 proposals per submitter.

All submission presenters will be required to agree to the Rx Summit Presentation Terms and Conditions before a proposal can be submitted.

Note: The Rx Summit National Advisory Board will accept presenter applications based on the following criteria:
  • Supporting evidence-based data from research or demonstrated results.
  • Intent to provide details on how to implement a successful program for others to replicate.

  • The Rx Summit National Advisory Board is seeking proposals that correspond to the following topic areas:

    (Please note that these are the categories for the submission process only and do not correspond to actual tracks at the Rx Summit. Track definitions and the number of tracks will be determined during the review process.)

    Advocacy – Activities and programs developed by community organizations, faith and family groups, prevention and education networks, public health agencies (local, state, federal, etc.), or private organizations that support legislative, community, and family support programs.

    Clinical – Strategies and outcomes that further the understanding of how to manage patients’ pain safely, address patients' addiction issues, mitigate risks associated with Rx opioids, and address health issues related to the opioid crisis (such as HIV and Hepatitis C infections) in all age demographics from pre-natal/NAS to older adults, as well as how to set up clinical practices to respond to the opioid crisis.

    Emergency Medical Services / First Responders – Current and future innovative strategies that address EMS and first responders’ role in treating and managing substance use disorder. Case presentations identifying novel and successful assessments, partnerships, stakeholder collaboration, provider and patient mental health, management, and treatment plans, as well as destination and follow-up options for patients.

    Fentanyl, Heroin & Other Illicit Drugs – Statistical analysis of emerging threats as well as new initiatives and proven strategies of policy, public health, and law enforcement tactics of federal, state, and local responses that have been implemented to respond to ever-changing drug use patterns, such as with heroin, fentanyl, and gabapentin.

    Law Enforcement & Corrections – Case studies from the federal, state, local, and tribal agencies, prosecutors, correctional institutions, and judicial systems who are implementing enforcement, treatment, and programs that identify new opportunities for prevention with stakeholders outside the law enforcement community.

    Overdose Prevention & Risk Reduction Strategies – Practical strategies and active programs aimed at reducing the negative consequences associated with drug use, such as overdose prevention, supervised injection facilities, field-based drug testing, and syringe access.

    Technology, PDMP & Data Surveillance – Federal, state, and local systems and strategies that formulate and improve the effective data gathering, sharing, and analysis through provider engagement and technology innovations.

    Prescription Practices / Third Party Payer – Proven prescription best practices, case studies, and policies and legislation from pharmacists and pharmacy benefit managers, dentists, anesthesiologists, as well as programs and successful efforts with commercial and employee health plans, workers’ compensation, and Medicare and Medicaid plans.

    Prevention Strategies – Research and proven programs that seek to prevent initial substance use, including the study of drug trends and responses, alternative pain management strategies, crafting communication and social media campaigns, and the implementation of effective youth prevention programs, including peer-to-peer models.

    Rural & Tribal Communities – Programs and initiatives being implemented to address the opioid epidemic in these hard-hit areas of the United States, which often lack the necessary resources needed to adequately address prevention and initiate treatment on a system-wide level.

    Special Populations – Programs that successfully tailor approaches to special populations, such as pediatric, elderly, minorities, over-the-road truckers, etc., or research that would inform such approaches.

    Stimulants – Practical strategies and solutions to address the country’s stimulant crisis, an under-recognized emergency compounding the opioid epidemic.

    Treatment & Recovery – Successful, outcome-based treatment and recovery programs in response to the opioid epidemic, including the discussion of the opportunities and challenges created by new federal laws, and treatment and recovery efforts for diverse populations, including veterans, older adults, etc.

    Workplace – Real-world examples of employers hiring people in recovery, addressing opioid use among their workforce, connecting employees to treatment, and supporting workers' recovery, including public-private partnerships.

    Click here to download and review the Rx Summit Presentation Terms and Conditions.
    Click here to download and review the Submission Guidelines.
    Click here to download the Frequently Asked Questions.

    Questions: Cindy Lackey at OR Michelle Hlavin at

    Login to the Abstract ScoreCard

    Questions? Organizer: Cindy Lackey -